Pancreaticojejunostomy of duct to mucosa anastomosis can be performed more safely without than with a stenting tube.
BACKGROUND
The aim of this study was to evaluate the safety of performing a pancreaticojejunostomy with a duct-to-mucosa anastomosis without a stenting tube.


METHODS
One hundred twenty-one patients with pancreaticojejunostomy, classified into 2 groups of those with duct-to-mucosa anastomoses with stenting tubes (group A; n = 49) and without stenting tubes (group B; n = 72), were investigated. Outcomes, including complications and survival rates, are reported.


RESULTS
In group A, morbidity was 32.7%, 6.7% had pancreatic fistulas, 14.3% had delayed gastric emptying, 6.1% had remnant pancreatitis, 2% had intra-abdominal abscesses, 2% had intra-abdominal bleeding, and mortality was 2%. In group B, morbidity (15.3%) and delayed gastric emptying (2.8%) showed significant differences from group A. Other results were nonsignificant. In the normal soft pancreas, pancreatic fistulas in group B (3.3%) were less frequent than in group A (12.5%).


CONCLUSIONS
Pancreaticojejunostomy of a duct-to-mucosa anastomosis could be performed more safely without than with a stenting tube to obtain a definitive anastomosis and transection of the pancreas.
Suzuki
Shuji
S
Department of Surgery, Hachioji Digestive Disease Hospital, Hachioji City, Tokyo, Japan. dr802@nifty.com
Kaji
Satoshi
S
Koike
Nobusada
N
Harada
Nobuhiko
N
Tanaka
Seiichi
S
Hayashi
Tsuneo
T
Suzuki
Mamoru
M
Hanyu
Fujio
F
D000368:Aged; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007413:Intestinal Mucosa / Q000473:pathology / Q000601:surgery; D007564:Japan / Q000453:epidemiology; D007583:Jejunum / Q000473:pathology / Q000601:surgery*; D008297:Male; D008875:Middle Aged; D009017:Morbidity / Q000639:trends; D010182:Pancreatic Diseases / Q000601:surgery*; D010183:Pancreatic Ducts / Q000473:pathology / Q000601:surgery*; D010193:Pancreaticojejunostomy / Q000379:methods*; D011183:Postoperative Complications / Q000453:epidemiology; D012189:Retrospective Studies; D015607:Stents; D015996:Survival Rate / Q000639:trends; D016896:Treatment Outcome